Insider · CIK 0001221449

WEISER MICHAEL

Reports to the SEC for 10 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001221449

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+90.3K sh	—	—	90,316
2025-06-13	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+67.5K sh	—	—	67,546
2024-06-11	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+49.3K sh	—	—	49,303
2024-03-01	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+100K sh	—	—	100,000
2023-06-06	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+52K sh	—	—	51,955
2022-06-10	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+51.2K sh	—	—	51,204
2022-05-31	IOVAIOVANCE BIOTHERAPEUTICS, INC.P Purchase	Director	PPurchase	+7,813 sh	$6.80	+$53.1K	112,632
2022-05-31	IOVAIOVANCE BIOTHERAPEUTICS, INC.P Purchase	Director	PPurchase	+2,187 sh	$6.79	+$14.8K	104,819
2021-06-29	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2020-06-08	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2019-06-10	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-07-17	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-03-15	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,021 sh	$4.14	−$24.9K	224,282
2017-12-29	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+17.3K sh	—	—	230,303
2017-12-08	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.73	+$54.6K	225,370
2017-12-08	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−12.3K sh	$4.43	−$54.6K	213,045
2017-12-08	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2017-06-12	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$4.85	+$72.8K	218,670
2017-06-12	TCRTAlaunos Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2017-06-12	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−13.3K sh	$5.47	−$72.8K	205,370
2017-05-18	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2016-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−9,331 sh	$5.35	−$49.9K	203,670
2016-12-30	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+17.2K sh	—	—	213,001
2016-05-25	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2016-04-19	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.01	+$75.2K	206,548
2016-04-19	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−10.8K sh	$8.88	−$95.5K	195,797
2016-04-19	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2015-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+26.7K sh	—	—	191,548
2015-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,047 sh	$8.31	−$17K	164,887
2015-05-20	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2015-03-03	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2014-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,047 sh	$5.07	−$10.4K	166,934
2014-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2014-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,051 sh	$5.03	−$10.3K	168,981
2014-01-22	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+52.5K sh	—	—	52,500
2013-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−5,854 sh	$4.34	−$25.4K	171,032
2013-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-05-30	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2013-04-15	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2013-01-07	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+52.5K sh	—	—	52,500
2012-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−1,904 sh	$4.21	−$8,015.84	176,886
2012-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+17.5K sh	—	—	178,790
2012-07-30	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2012-07-23	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2012-06-05	Chelsea Therapeutics International, Ltd.P Purchase	Director	PPurchase	+100 sh	$1.32	+$132	445,278
2012-06-05	Chelsea Therapeutics International, Ltd.P Purchase	Director	PPurchase	+4,900 sh	$1.32	+$6,467.51	450,178
2012-05-31	EMISPHERE TECHNOLOGIES INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	216,000
2012-05-31	TCRTAlaunos Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+35.6K sh	$3.93	+$140K	189,088
2012-05-31	TCRTAlaunos Therapeutics, Inc.J Other	Director	JOther	−27.8K sh	$5.02	−$140K	161,244

Recent filings

Accepted (ET)
Jun 184
WEISER MICHAEL0001104659-26-075863
SEC(opens sec.gov)
Jun 174
WEISER MICHAEL0001104659-25-060251
SEC(opens sec.gov)
Jun 134
WEISER MICHAEL0001104659-24-071372
SEC(opens sec.gov)
Mar 54
WEISER MICHAEL0001104659-24-031111
SEC(opens sec.gov)
Jun 84
WEISER MICHAEL0001104659-23-069506
SEC(opens sec.gov)
Jun 144
WEISER MICHAEL0001104659-22-071053
SEC(opens sec.gov)
Jun 24
WEISER MICHAEL0001104659-22-067761
SEC(opens sec.gov)
Jul 14
WEISER MICHAEL0001104659-21-088253
SEC(opens sec.gov)
Jun 104
WEISER MICHAEL0001104659-20-072139
SEC(opens sec.gov)
Jun 114
WEISER MICHAEL0001144204-19-030597
SEC(opens sec.gov)
Jul 194
WEISER MICHAEL0001250853-18-000103
SEC(opens sec.gov)
Mar 194
WEISER MICHAEL0001250853-18-000043
SEC(opens sec.gov)
Jan 34
WEISER MICHAEL0001209191-18-001023
SEC(opens sec.gov)
Dec 114
WEISER MICHAEL0001209191-17-065008
SEC(opens sec.gov)
Jun 144
ZIOPHARM ONCOLOGY INC0001209191-17-039824
SEC(opens sec.gov)

Companies

Address

C/O IOVANCE BIOTHERAPEUTICS, INC. 825 INDUSTRIAL ROAD, SUITE 100

SAN CARLOS, CA, 94070